[HTML][HTML] The Acute Effects of Amyloid-Beta1–42 on Glutamatergic Receptor and Transporter Expression in the Mouse Hippocampus

JHY Yeung, TH Palpagama, WP Tate… - Frontiers in …, 2020 - frontiersin.org
Alzheimer's disease (AD) is the leading type of dementia worldwide. Despite an increasing
burden of disease due to a rapidly aging population, there is still a lack of complete …

[HTML][HTML] The Acute Effects of Amyloid-Beta1–42 on Glutamatergic Receptor and Transporter Expression in the Mouse Hippocampus

JHY Yeung, TH Palpagama, WP Tate… - Frontiers in …, 2019 - ncbi.nlm.nih.gov
Alzheimer's disease (AD) is the leading type of dementia worldwide. Despite an increasing
burden of disease due to a rapidly aging population, there is still a lack of complete …

The Acute Effects of Amyloid-Beta1–42 on Glutamatergic Receptor and Transporter Expression in the Mouse Hippocampus.

JHY Yeung, TH Palpagama, WP Tate… - Frontiers in …, 2020 - search.ebscohost.com
Alzheimer's disease (AD) is the leading type of dementia worldwide. Despite an increasing
burden of disease due to a rapidly aging population, there is still a lack of complete …

The Acute Effects of Amyloid-Beta1-42 on Glutamatergic Receptor and Transporter Expression in the Mouse Hippocampus

JHY Yeung, TH Palpagama, WP Tate… - Frontiers in …, 2020 - pubmed.ncbi.nlm.nih.gov
Alzheimer's disease (AD) is the leading type of dementia worldwide. Despite an increasing
burden of disease due to a rapidly aging population, there is still a lack of complete …

The Acute Effects of Amyloid-Beta1-42 on Glutamatergic Receptor and Transporter Expression in the Mouse Hippocampus.

JHY Yeung, TH Palpagama, WP Tate… - Frontiers in …, 2020 - europepmc.org
Alzheimer's disease (AD) is the leading type of dementia worldwide. Despite an increasing
burden of disease due to a rapidly aging population, there is still a lack of complete …